Why randomized trials for proton therapy are difficult to complete (and what we can do about it): Experts lay out strategies to tackle key barriers in proton research

Comments Off on Why randomized trials for proton therapy are difficult to complete (and what we can do about it): Experts lay out strategies to tackle key barriers in proton research

Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new therapies with

Model automates molecule design to speed drug development: Machine-learning model could help chemists make molecules with higher potencies, much more quickly.

Comments Off on Model automates molecule design to speed drug development: Machine-learning model could help chemists make molecules with higher potencies, much more quickly.

Designing new molecules for pharmaceuticals is primarily a manual, time-consuming process that’s prone to error. But MIT researchers have now

Cells stop dividing when this gene kicks into high gear: Discovery — centered on a gene called CD36 — illuminates a process tied to the aging of cells and organisms

Comments Off on Cells stop dividing when this gene kicks into high gear: Discovery — centered on a gene called CD36 — illuminates a process tied to the aging of cells and organisms

Scientists seeking to unlock the secrets of cellular aging have identified a gene that triggers senescence, a phenomenon in which

Profiling the genome hundreds of variations at a time: A CRISPR-Cas9 high-throughput strategy creates the possibility to rapidly profile and identify genes and DNA sequence variations key to different traits and diseases

Comments Off on Profiling the genome hundreds of variations at a time: A CRISPR-Cas9 high-throughput strategy creates the possibility to rapidly profile and identify genes and DNA sequence variations key to different traits and diseases

Geneticists have been using model organisms ranging from the house mouse to the single-cell bakers’ yeast, Saccharomyces cerevisiae, to study